EUVIMEDEUVIMED entdecken
Crossref

Clinical and microbiological characteristics of rifampicin-resistant MRSA bacteraemia

Seongman Bae, Eun Sil Kim, Yun Woo Lee iD, Jiwon Jung, Min Jae Kim, Yong Pil Chong, Sung-Han Kim, Sang-Ho Choi, Sang-Oh Lee, Yang Soo Kim

Journal of Antimicrobial Chemotherapy · 2023

DOI: 10.1093/jac/dkac428 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Antimicrobial Chemotherapy, 2023. Verfasst von Seongman Bae und 9 weiteren Autor:innen. Beteiligte Einrichtung: Division of Infectious Diseases, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Ko…. Hauptthemen laut MEDLINE: Methicillin-Resistant Staphylococcus aureus, Staphylococcal Infections, Bacteremia. Die Arbeit wurde bisher 7-mal zitiert (Crossref) und nennt 35 Literaturangaben. Gefördert von: Korea Health Technology R&D Project, Korea Health Industry Development Institute, Ministry of Health & Welfare, Republic of Korea.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objectives

The clinical significance of rifampicin resistance in Staphylococcus aureus infections has not been demonstrated. Here, we evaluated the clinical characteristics of rifampicin-resistant S. aureus infection.

Methods

Data were collected from adult patients who were hospitalized with MRSA bacteraemia between March 2007 and May 2020 at a tertiary hospital in South Korea. The clinical characteristics and treatment outcomes of patients infected with rifampicin-resistant MRSA were compared with those of rifampicin-susceptible isolates. All-cause death and recurrence of MRSA infection were assessed for 90 days.

Results

Of the 961 patients with MRSA bacteraemia, 61 (6.3%) were infected by rifampicin-resistant isolates. The type of infection focus and duration of bacteraemia did not significantly differ between the two groups. Rifampicin-resistant MRSA isolates were more likely to have multidrug resistance and a higher vancomycin MIC relative to the rifampicin-susceptible isolates. The 90-day recurrence rate was higher in the patients infected with rifampicin-resistant MRSA compared with those with rifampicin-susceptible MRSA (18.0% versus 6.2%, P < 0.001), whereas the 90-day mortality was comparable between the two groups (27.9% versus 29.2%, P = 0.94). After adjusting for potential confounding factors, rifampicin resistance was significantly associated with 90-day recurrence (subdistributional HR: 2.31; 95% CI: 1.05–5.10; P = 0.04).

Conclusions

Rifampicin-resistant MRSA isolates showed distinct microbiological features in terms of multidrug resistance and a high vancomycin MIC. Although the management of MRSA bacteraemia was not significantly different between the two groups, recurrence was significantly more common in the rifampicin-resistant group. Rifampicin resistance may play a significant role in infection recurrence.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Methicillin-Resistant Staphylococcus aureusStaphylococcal InfectionsBacteremiaAdultHumansRifampinVancomycinAnti-Bacterial AgentsMicrobial Sensitivity Tests

Substanzen

RifampinVancomycinAnti-Bacterial Agents

Autor:innen und Institutionen

  • Division of Infectious Diseases, Department of Internal Medicine, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Republic of Korea.
  • Center for Antimicrobial Resistance and Microbial Genetics, University of Ulsan College of Medicine, Seoul, Republic of Korea.

ORCID-Profile: Yun Woo Lee

Förderung

  • Korea Health Technology R&D Project
  • Korea Health Industry Development Institute
  • Ministry of Health & Welfare, Republic of Korea

Zitieren

APA

Bae, S., Kim, E. S., Lee, Y. W., Jung, J., Kim, M. J., Chong, Y. P., Kim, S. H., Choi, S. H., Lee, S. O., & Kim, Y. S. (2023). Clinical and microbiological characteristics of rifampicin-resistant MRSA bacteraemia. Journal of Antimicrobial Chemotherapy. https://doi.org/10.1093/jac/dkac428

Vancouver

Bae S, Kim ES, Lee YW, Jung J, Kim MJ, Chong YP, et al. Clinical and microbiological characteristics of rifampicin-resistant MRSA bacteraemia. Journal of Antimicrobial Chemotherapy. 2023. doi:10.1093/jac/dkac428

BibTeX
@article{Bae2023,
  author = {Bae, Seongman and Kim, Eun Sil and Lee, Yun Woo and Jung, Jiwon and Kim, Min Jae and Chong, Yong Pil and Kim, Sung-Han and Choi, Sang-Ho and Lee, Sang-Oh and Kim, Yang Soo},
  title = {Clinical and microbiological characteristics of rifampicin-resistant MRSA bacteraemia},
  journal = {Journal of Antimicrobial Chemotherapy},
  year = {2023},
  doi = {10.1093/jac/dkac428}
}
Kostenlos starten →